AGAP1/AP-3-dependent endocytic recycling of M5 muscarinic receptors promotes dopamine release. - Wikidata - awgldk - TriplyDB

AGAP1/AP-3-dependent endocytic recycling of M5 muscarinic receptors promotes dopamine release.

AGAP1/AP-3-dependent endocytic recycling of M5 muscarinic receptors promotes dopamine release.

http://www.wikidata.org/entity/Q34076241

about

Dopamine release in the basal ganglia How addictive drugs disrupt presynaptic dopamine neurotransmission The Road not Taken: Less Traveled Roads from the TGN to the Plasma Membrane Genome-wide methylation analysis of a large population sample shows neurological pathways involvement in chronic widespread musculoskeletal pain.Somatodendritic targeting of M5 muscarinic receptor in the rat ventral tegmental area: implications for mesolimbic dopamine transmission Muscarinic regulation of dopamine and glutamate transmission in the nucleus accumbens.Striatal dopamine neurotransmission: regulation of release and uptake ArfGAPs: key regulators for receptor sorting.ArfGAP1 promotes COPI vesicle formation by facilitating coatomer polymerization Unraveling a molecular determinant for clathrin-independent internalization of the M2 muscarinic acetylcholine receptor.Cholinergic interneurons in the dorsal and ventral striatum: anatomical and functional considerations in normal and diseased conditions Gene Expression Differences in Peripheral Blood of Parkinson's Disease Patients with Distinct Progression Profiles AP-3 regulates PAR1 ubiquitin-independent MVB/lysosomal sorting via an ALIX-mediated pathway.Cholinergic connectivity: it's implications for psychiatric disorders.Allosteric properties of PH domains in Arf regulatory proteins.AGAP3 and Arf6 regulate trafficking of AMPA receptors and synaptic plasticity.Upregulation of μ3A Drives Homeostatic Plasticity by Rerouting AMPAR into the Recycling Endosomal Pathway.M5 receptor activation produces opposing physiological outcomes in dopamine neurons depending on the receptor's location Regulation of striatal dopamine release by presynaptic auto- and heteroreceptors.Emerging approaches for treatment of schizophrenia: modulation of cholinergic signaling.Muscarinic acetylcholine receptors: novel opportunities for drug development.Extended access oxycodone self-administration and neurotransmitter receptor gene expression in the dorsal striatum of adult C57BL/6 J mice.Putative terminator and/or effector functions of Arf GAPs in the trafficking of clathrin-coated vesicles.Endocannabinoid modulation of dopamine neurotransmission.Multivariate Imaging Genetics Study of MRI Gray Matter Volume and SNPs Reveals Biological Pathways Correlated with Brain Structural Differences in Attention Deficit Hyperactivity Disorder.Microscopic binding of M5 muscarinic acetylcholine receptor with antagonists by homology modeling, molecular docking, and molecular dynamics simulation The Endosome Localized Arf-GAP AGAP1 Modulates Dendritic Spine Morphology Downstream of the Neurodevelopmental Disorder Factor Dysbindin.Direct Functional Interaction of the Kinesin-13 Family Membrane Kinesin-like Protein 2A (Kif2A) and Arf GAP with GTP-binding Protein-like, Ankyrin Repeats and PH Domains1 (AGAP1).Dopamine signaling in dorsal versus ventral striatum: the dynamic role of cholinergic interneurons.Physiological roles of CNS muscarinic receptors gained from knockout mice.M1 muscarinic activation induces long-lasting increase in intrinsic excitability of striatal projection neurons.Arf GAPs and molecular motors.Cholinergic Projections to the Substantia Nigra Pars Reticulata Inhibit Dopamine Modulation of Basal Ganglia through the M4 Muscarinic Receptor.p11 in Cholinergic Interneurons of the Nucleus Accumbens Is Essential for Dopamine Responses to Rewarding Stimuli Acetylcholine Neurotransmitter Receptor Densities in the Striatum of Hemiparkinsonian Rats Following Botulinum Neurotoxin-A Injection

P2860

Q22251247-C4851C8D-F553-455C-AFFF-8A9E5EA3D3A8 Q24631269-D6C73EDD-6CA4-480B-949D-A189E8C7A508 Q28082121-6BB7A48F-900C-445C-BFD3-83708018D28D Q33669877-B4C3F0BF-041E-47D8-9F71-F1C1142B9D5F Q33683909-21F24FB0-678C-4615-84EB-ED4B69C45016 Q34480978-521576FE-94F4-40C3-A72A-60CADC4D7845 Q34524803-B419D80D-7B34-4BE4-9E39-6F38B4D48A69 Q35672450-006C6B8A-DB3E-4141-8551-E0753FD44912 Q35694109-22216532-C78A-40C2-8B1D-F3551B3C54EF Q35764696-424A2C0C-7858-4611-B8CD-F05A571BA39F Q36042479-9F996F20-0910-44AA-83F5-2C6175E5C41F Q36056735-B8E68E8F-C66A-4BFC-9F92-343727202A51 Q36234486-3033309B-FE02-40E1-BA1E-0C190431DE04 Q36812599-01BFE227-EABC-41F5-8A4C-F0773F89D5C6 Q36931366-0633B28E-0066-4ED2-A640-1D773194B75E Q37058102-F5EA9E5D-3C8E-4932-8444-9296C8206C9E Q37580094-C97C343C-9FCA-4004-B5BD-F907F207C3F9 Q37603769-83B8B4F4-A16F-4DCB-A9DD-C47050DA2723 Q38019926-98056B0D-D9DD-4AFD-8234-F571DB3FE7A7 Q38070176-1ACA18E9-F4AF-4C9D-8FB8-73435D8D8722 Q38218059-08EEA3C8-89BE-4D14-87D8-208CFCE8B0BB Q38279982-FCFE92C3-EE3F-4D53-932B-14DADCC415FC Q38437191-E466F70C-21C3-46CF-BD31-B0776128E9DB Q39267685-82DCDE1C-AA48-4207-ADBC-775271F6A53B Q39509266-B76F514B-218E-4871-9F7B-43605EAE1D32 Q40370946-05331BE9-DF08-42F3-AA30-E8D3F061B444 Q41145637-58DD6830-10A3-4CB3-B5C5-26080AD1DDD9 Q41890412-3BD4FA14-A246-4CA0-869B-CE2921DB9855 Q42652289-EF1BA21F-40D4-4CD4-9785-FBD980EFE420 Q43076051-9F5B6E0F-7A2D-4794-8876-84A973194C66 Q48248520-3AFCFE65-721F-4BBA-90D1-E68964C9180D Q51042462-837D871C-A36C-4870-844F-9EAD26676DFA Q52740407-01447384-D959-42C3-B475-AC0866FC0E8A Q58699601-28CC6710-B34D-4C40-B051-A925DDD7EE32 Q58790106-09FA3867-F731-4D9C-9372-48BE2D22FFF1

P2860

AGAP1/AP-3-dependent endocytic recycling of M5 muscarinic receptors promotes dopamine release.

http://www.wikidata.org/entity/Q34076241

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

AGAP1/AP-3-dependent endocytic ...... ors promotes dopamine release.

@ast

AGAP1/AP-3-dependent endocytic ...... ors promotes dopamine release.

@en

AGAP1/AP-3-dependent endocytic ...... ors promotes dopamine release.

@nl

type

label

AGAP1/AP-3-dependent endocytic ...... ors promotes dopamine release.

@ast

AGAP1/AP-3-dependent endocytic ...... ors promotes dopamine release.

@en

AGAP1/AP-3-dependent endocytic ...... ors promotes dopamine release.

@nl

prefLabel

AGAP1/AP-3-dependent endocytic ...... ors promotes dopamine release.

@ast

AGAP1/AP-3-dependent endocytic ...... ors promotes dopamine release.

@en

AGAP1/AP-3-dependent endocytic ...... ors promotes dopamine release.

@nl

P1433

Q34076241-9BF7FF59-E0D1-45E4-AA33-0A1376C938E2

P1476

Q34076241-A39F9F66-666B-46CD-A89E-CE1011B82B46

P2093

Q34076241-0CFEC9D5-4DBB-4364-85C6-DC75F4CE2875

Q34076241-5B505901-0CB0-4D75-A6E0-8F5772B84D38

Q34076241-5C76B56A-E32A-4B47-88BF-81339689A37E

Q34076241-B0482016-FF69-4062-B744-2AD5034FDA7B

P2860

Q34076241-0502DAFB-C67E-485D-8ECC-6760F87590AF

Q34076241-08AD1460-DE2A-4A66-A2F3-15BAD752CCB2

Q34076241-090911B5-29F6-4BDE-AEA0-16819B0D2396

Q34076241-0B4ADCD7-E21F-4119-92A4-440A42992390

Q34076241-0ED2FD5A-124A-4243-B2F3-76C468C27234

Q34076241-115C071C-0623-43C0-9280-4C7D79B5994F

Q34076241-196EC5B6-6818-4874-BF16-520C678338A1

Q34076241-22FD44D1-5077-459B-AD71-D2A7EE66F6E5

Q34076241-2328447D-9FE5-4006-91DA-5C2CD2A62DD9

Q34076241-24B8E623-9730-4481-93D3-DE22B82DFEE6

P304

Q34076241-BA2367B2-71B1-4467-A5DF-CC9F8D379373

P31

Q34076241-22BA5159-E055-40AB-9B4F-68ACE3BCA7FD

P356

Q34076241-D5AF616E-AA58-4AF4-A6BD-4198F4BED26E

P407

Q34076241-271C0D21-25B3-499D-98B2-DF09B75B2161

P433

Q34076241-0EDAF9A1-C239-42C5-A494-795BA63E3299

P478

Q34076241-D28FBEA4-D144-4F0F-BB9E-85EA85D4F4C6

P50

Q34076241-4880F4FA-A12A-4DE6-AB5E-D7789A4914A8

Q34076241-5F16443E-E9CF-4545-A9C7-12F9987C05BE

Q34076241-7488BC78-5C74-4B5C-9D79-C22153E5C026

Q34076241-7F99E94A-077A-455A-A784-5E063A2EA6A8

P577

Q34076241-28DD5E09-E503-47EA-AE49-A361B6AF636C

P5875

Q34076241-6742548F-AE5D-4FC2-9841-B25924EBD399

P698

Q34076241-2CF74036-9AEC-4A62-9A04-4F4ED19C4734

P921

Q34076241-effbde42-a0d2-4b4d-b5b7-bc09b7c1984f

P932

Q34076241-ECF07F87-FB45-451A-89EB-377E013E9515

P356

P1433

The EMBO Journal

P1476

AGAP1/AP-3-dependent endocytic ...... ors promotes dopamine release.

@en

P2093

Hugh C Hemmings

http://www.w3.org/2001/XMLSchema#string

José E Lizardi-Ortiz

http://www.w3.org/2001/XMLSchema#string

Markus Brandstetter

http://www.w3.org/2001/XMLSchema#string

Robert I Westphalen

http://www.w3.org/2001/XMLSchema#string

P2860

Altered trafficking of lysosomal proteins in Hermansky-Pudlak syndrome due to mutations in the beta 3A subunit of the AP-3 adaptor

beta-Arrestin: a protein that regulates beta-adrenergic receptor function

FAPPs control Golgi-to-cell-surface membrane traffic by binding to ARF and PtdIns(4)P

GGAPs, a new family of bifunctional GTP-binding and GTPase-activating proteins

The zinc transporter ZnT3 interacts with AP-3 and it is preferentially targeted to a distinct synaptic vesicle subpopulation

Hermansky-Pudlak syndrome type 7 (HPS-7) results from mutant dysbindin, a member of the biogenesis of lysosome-related organelles complex 1 (BLOC-1)

Common variants on chromosome 6p22.1 are associated with schizophrenia

Keeping G proteins at bay: a complex between G protein-coupled receptor kinase 2 and Gbetagamma

Sequence and structure-based prediction of eukaryotic protein phosphorylation sites

Specific regulation of the adaptor protein complex AP-3 by the Arf GAP AGAP1

P304

2813-2826

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/EMBOJ.2010.154

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-07-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45389459

http://www.w3.org/2001/XMLSchema#string

P698

20664521

http://www.w3.org/2001/XMLSchema#string

P921

P932

2924642

http://www.w3.org/2001/XMLSchema#string